On March 30, 2022, Alfred Altomari, the Chairman of the Board of Directors (the Board) of Baudax Bio, Inc. (the Company), notified the Company of his intent to resign from the Board immediately following the Company's 2022 Annual Meeting of Shareholders (the Annual Meeting). On May 4, the Company held its Annual Meeting, but adjourned until May 18, 2022 at 9:00 A.M. Eastern Time to allow more time to establish a quorum. In addition, effective on May 2, 2022, the Board appointed Mr. Wayne Weisman as the Chairman of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | -7.49% | 0.00% | -54.55% |
Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-54.55% | 525K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. Announces Management Changes